RESEARCH PAPER
High levels of vitamin D associated with less ischemic heart disease – a nested case-control study among rural men in Sweden
 
More details
Hide details
1
Department of Research and Development, Region Kronoberg, Växjö, Sweden
2
Division of Occupational and Environmental Medicine, Institute of Laboratory Medicine, Lund University, Lund, Sweden
3
Department of Public Health and Caring Sciences, Family Medicine and Clinical epidemiological Sections, Uppsala University, Sweden
 
Ann Agric Environ Med 2017;24(2):288–293
KEYWORDS:
ABSTRACT:
Introduction and objective:
Low levels of serum vitamin D have been associated with increased occurrence of ischemic heart disease (IHD), but findings are inconsistent, e.g. seasonal variation is not always considered in the analyses. The aim of this study was to investigate whether vitamin D is associated with IHD among rural middle-aged men in Sweden when seasonal variation is taken into account.

Material and Methods:
A nested case-control study was performed within a population-based cohort of Swedish farmers and rural residents followed for 20 years. Outcomes were from national health registers. For 276 cases (IHD at any time during follow-up), and for 276 aged-matched controls free of cardiovascular diseases or diabetes, serum levels of vitamin D (25-hydroxyvitamin D3) were analyzed with liquid chromatography/tandem mass spectrometry (LC/MS/MS), in stored blood samples drawn at the baseline survey in 1990–91. The odds ratio (OR) with 95% confidence intervals (CI) of IHD for vitamin D-quartiles (based on measured as well as adjusted for month of sampling) was evaluated in logistic regression models; potential confounders were taken into account.

Results:
The measured mean vitamin D levels were 27.6 ng/ml(standard deviation (sd)8.2 ng/ml) and 28.8 ng/ml (sd 9.0) among cases and controls, respectively. Compared to the quartile with the lowest month-adjusted vitamin D levels, the risk of IHD was significantly lower in the highest quartile (OR=0.46, 95% CI 0.25–0.84, p=0.012) in the fully-adjusted model.

Conclusions:
Rural Swedish men in the highest quartile of serum vitamin D had halved relative risk of IHD, compared to those in the lowest quartile.

CORRESPONDING AUTHOR:
Sara Holmberg   
Department of Research and Development, Region Kronoberg, Växjö, Sweden
 
REFERENCES (48):
1. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008; 87(4): 1080S-6S.
2. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007; 66(9): 1137–42.
3. Klampfer L. Vitamin D and colon cancer. World J Gastrointest Oncol. 2014; 6(11): 430–7.
4. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014; 348: g1903.
5. Schottker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot L, et al. Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ. 2014; 348: g3656.
6. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008; 168(11): 1174–80.
7. Wang L, Song Y, Manson JE, Pilz S, Marz W, Michaelsson K, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012; 5(6): 819–29.
8. Kunadian V, Ford GA, Bawamia B, Qiu W, Manson JE. Vitamin D deficiency and coronary artery disease: a review of the evidence. Am Heart J. 2014; 167(3): 283–91.
9. Perna L, Schottker B, Holleczek B, Brenner H. Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: a prospective study with repeated measurements. J Clin Endocrinol Metab. 2013; 98(12): 4908–15.
10. Schnatz PF, Manson JE. Vitamin D and cardiovascular disease: an appraisal of the evidence. Clin Chem. 2014; 60(4): 600–9.
11. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2014; 1: CD007470.
12. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005; 97(1–2): 93–101.
13. Karatsoreos IN, McEwen BS. Psychobiological allostasis: resistance, resilience and vulnerability. Trends Cogn Sci. 2011; 15(12): 576–84.
14. Brustad M, Alsaker E, Engelsen O, Aksnes L, Lund E. Vitamin D status of middle-aged women at 65–71 degrees N in relation to dietary intake and exposure to ultraviolet radiation. Public Health Nutr. 2004; 7(2): 327–35.
15. Klingberg E, Olerod G, Konar J, Petzold M, Hammarsten O. Seasonal variations in serum 25-hydroxy vitamin D levels in a Swedish cohort. Endocrine. 2015: DOI 10.1007/s12020-015-0548-3.
16. Hypponen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007; 85(3): 860–8.
17. Lindqvist PG, Epstein E, Landin-Olsson M, Ingvar C, Nielsen K, Stenbeck M, et al. Avoidance of sun exposure is a risk factor for all-cause mortality: results from the Melanoma in Southern Sweden cohort. J Intern Med. 2014; 276(1): 77–86.
18. Thelin A. Morbidity in Swedish farmers, 1978–1983, according to national hospital records. Soc Sci Med. 1991; 32(3): 305–9.
19. Thelin N, Holmberg S, Nettelbladt P, Thelin A. Mortality and morbidity among farmers, nonfarming rural men, and urban referents: a prospective population-based study. Int J Occup Environ Health. 2009; 15(1): 21–8.
20. Notkola VJ, Husman KR, Laukkanen VJ. Mortality among male farmers in Finland during 1979–1983. Scand J Work Environ Health. 1987; 13(2): 124–8.
21. Stark AD, Chang HG, Fitzgerald EF, Riccardi K, Stone RR. A retrospective cohort study of mortality among New York State Farm Bureau members. Arch Environ Health. 1987; 42(4): 204–12.
22. Devgun MS, Paterson CR, Johnson BE, Cohen C. Vitamin D nutrition in relation to season and occupation. Am J Clin Nutr. 1981; 34(8): 1501–4.
23. Azizi E, Pavlotsky F, Vered I, Kudish AI. Occupational exposure to solar UVB and seasonal monitoring of serum levels of 25-hydroxy vitamin D3: a case-control study. Photochem Photobiol. 2009; 85(5): 1240–4.
24. Nerbrand C, Aberg H, Rosen M, Tibblin G. [Regional mortality variations in middle Sweden]. Lakartidningen. 1985; 82(46): 4004–8.
25. Holmberg S, Stiernström EL, Thelin A, Svärdsudd K. Musculoskeletal symptoms among farmers and non-farmers: a population-based study. Int J Occup Environ Health. 2002; 8(4): 339–45.
26. Socialstyrelsen. International Classification of Diseases, Ninth Revision (ICD-9), Swedish version. Stockholm, Sweden: Liber/Allmänna förlaget; 1986.
27. Socialstyrelsen. International statistical classification of diseases and related health problems, Tenth revision (ICD-10), Swedish version. Uppsala, Sweden: Almqvist & Wiksell; 1997.
28. Gustafsson P, Rylander L, Lindh CH, Jonsson BA, Ode A, Olofsson P, et al. Vitamin D Status at Birth and Future Risk of Attention Deficit/Hyperactivity Disorder (ADHD). PLoS One. 2015; 10(10): e0140164.
29. Tornvall G. Assessment of physical capabilities. Acta Physiologica Scandinavica. 1963; 58(201): 17–55.
30. Karasek R, Brisson C, Kawakami N, Houtman I, Bongers P, Amick B. The Job Content Questionnaire (JCQ): an instrument for internationally comparative assessments of psychosocial job characteristics. J Occup Health Psychol. 1998; 3(4): 322–55.
31. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008; 117(4): 503–11.
32. Schottker B, Haug U, Schomburg L, Kohrle J, Perna L, Muller H, et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr. 2013; 97(4): 782–93.
33. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008; 168(15): 1629–37.
34. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011; 96(1): 53–8.
35. Kilkkinen A, Knekt P, Aro A, Rissanen H, Marniemi J, Heliovaara M, et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol. 2009; 170(8): 1032–9.
36. Messenger W, Nielson CM, Li H, Beer T, Barrett-Connor E, Stone K, et al. Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. Nutr Metab Cardiovasc Dis. 2012; 22(10): 856–63.
37. Schottker B, Saum KU, Perna L, Ordonez-Mena JM, Holleczek B, Brenner H. Is vitamin D deficiency a cause of increased morbidity and mortality at older age or simply an indicator of poor health? Eur J Epidemiol. 2014; 29(3): 199–210.
38. Verdoia M, Schaffer A, Sartori C, Barbieri L, Cassetti E, Marino P, et al. Vitamin D deficiency is independently associated with the extent of coronary artery disease. Eur J Clin Invest. 2014; 44(7): 634–42.
39. Linos E, Keiser E, Kanzler M, Sainani KL, Lee W, Vittinghoff E, et al. Sun protective behaviors and vitamin D levels in the US population: NHANES 2003–2006. Cancer Causes Control. 2012; 23(1): 133–40.
40. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004; 351(25): 2599–610.
41. Christodoulidis G, Vittorio TJ, Fudim M, Lerakis S, Kosmas CE. Inflammation in coronary artery disease. Cardiol Rev. 2014; 22(6): 279–88.
42. Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L. Vitamin D3: a helpful immuno-modulator. Immunology. 2011; 134(2): 123–39.
43. Waldron JL, Ashby HL, Cornes MP, Bechervaise J, Razavi C, Thomas OL, et al. Vitamin D: a negative acute phase reactant. J Clin Pathol. 2013; 66(7): 620–2.
44. Albert PJ, Proal AD, Marshall TG. Vitamin D: the alternative hypothesis. Autoimmun Rev. 2009; 8(8): 639–44.
45. Ghafouri B, Carlsson A, Holmberg S, Thelin A, Tagesson C. Biomarkers of systemic inflammation in farmers with musculoskeletal disorders; a plasma proteomic study. BMC Musculoskelet Disord. 2016; 17: 206.
46. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013; 369(21): 1991–2000.
47. Colak A, Toprak B, Dogan N, Ustuner F. Effect of sample type, centrifugation and storage conditions on vitamin D concentration. Biochem Med (Zagreb). 2013; 23(3): 321–5.
48. Agborsangaya C, Toriola AT, Grankvist K, Surcel HM, Holl K, Parkkila S, et al. The effects of storage time and sampling season on the stability of serum 25-hydroxy vitamin D and androstenedione. Nutr Cancer. 2010; 62(1): 51–7.
eISSN:1898-2263
ISSN:1232-1966